JP2024543187A5 - - Google Patents
Info
- Publication number
- JP2024543187A5 JP2024543187A5 JP2024531728A JP2024531728A JP2024543187A5 JP 2024543187 A5 JP2024543187 A5 JP 2024543187A5 JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024531728 A JP2024531728 A JP 2024531728A JP 2024543187 A5 JP2024543187 A5 JP 2024543187A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- sulfonic acid
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306658.2 | 2021-11-29 | ||
| EP21306658 | 2021-11-29 | ||
| PCT/EP2022/083709 WO2023094699A1 (fr) | 2021-11-29 | 2022-11-29 | Inhibiteurs de la phosphorylation anormale et de l'agrégation de la protéine tau |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543187A JP2024543187A (ja) | 2024-11-19 |
| JP2024543187A5 true JP2024543187A5 (cg-RX-API-DMAC10.html) | 2025-11-28 |
Family
ID=78851140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024531728A Pending JP2024543187A (ja) | 2021-11-29 | 2022-11-29 | タウタンパク質の異常リン酸化及び凝集の阻害物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250034194A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4441064A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024543187A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118922429A (cg-RX-API-DMAC10.html) |
| CA (1) | CA3240163A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023094699A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240409505A1 (en) * | 2023-06-12 | 2024-12-12 | The Procter & Gamble Company | Gluconamide sulfate surfactants |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5686603A (en) * | 1995-05-04 | 1997-11-11 | Lever Brothers Company, Division Of Conopco, Inc. | Sulfated polyhydroxy compounds as anionic surfactants and a process for their manufacture |
| WO2007115372A1 (en) * | 2006-04-10 | 2007-10-18 | Monash University | A method of modulating beta-amyloid peptide production |
-
2022
- 2022-11-29 CA CA3240163A patent/CA3240163A1/fr active Pending
- 2022-11-29 JP JP2024531728A patent/JP2024543187A/ja active Pending
- 2022-11-29 WO PCT/EP2022/083709 patent/WO2023094699A1/fr not_active Ceased
- 2022-11-29 CN CN202280089714.7A patent/CN118922429A/zh active Pending
- 2022-11-29 EP EP22823041.3A patent/EP4441064A1/fr active Pending
- 2022-11-29 US US18/714,018 patent/US20250034194A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102906091B (zh) | 苦参酸/碱衍生物及其制备方法和用途 | |
| CN111225896B (zh) | 免疫调节剂化合物 | |
| JP6431155B2 (ja) | フェノール誘導体及びその製造方法及び医薬的な応用 | |
| JP2017128605A (ja) | 抗ウイルス化合物の固体形態 | |
| LV12515B (en) | NON-FERTILIZING LIGANDS FOR ESTROGENE RECYCLES | |
| CN116917280A (zh) | 四氢萘类化合物、其制备方法及其在医药上的应用 | |
| JP2018528222A (ja) | デングウイルス複製阻害剤としての一または二置換インドール誘導体 | |
| US9975856B2 (en) | Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid | |
| CN107848952B (zh) | 稠合三环γ-氨基酸衍生物及其制备方法和在医药上的应用 | |
| KR20170005888A (ko) | 신규 1-아릴-3-아자바이사이클로[3.1.0]헥산:제조 방법 및 신경 정신 질환 치료를 위한 용도 | |
| WO2004058744A1 (fr) | Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation son application en therapeutique | |
| EA029088B1 (ru) | Макроциклические и бициклические ингибиторы вируса гепатита c | |
| JP2025507851A5 (cg-RX-API-DMAC10.html) | ||
| ES2573004T3 (es) | Compuestos bicíclicos de tetrahidropirrol | |
| TW202000652A (zh) | 飽和環稠合二氫嘧啶酮或二氫三酮化合物及其醫藥用途 | |
| CN103153297A (zh) | 类萜类似物及其用于治疗神经病症的用途 | |
| IE67814B1 (en) | Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases | |
| TWI338687B (cg-RX-API-DMAC10.html) | ||
| WO2019108943A1 (en) | Benzene fused heterocyclic compound and use thereof | |
| AR069249A1 (es) | Derivado de indazol, activo en el dolor neuropatico | |
| KR20230172552A (ko) | Tead 억제제 | |
| JP7734361B2 (ja) | 化合物又はその塩及びその製造方法、化合物又はその塩を含む医薬品組成物及びその製造方法 | |
| CA2754384A1 (en) | Pharmaceutical hypocholesterolemic compositions | |
| ATE445589T1 (de) | Neue retinoidderivate und eine pharmazeutische anti-krebs-zusammensetzung, die diese verbindungen enthält | |
| KR101428496B1 (ko) | 미토콘드리아 기능 조절에 활성을 지닌 트리아졸 유도체 |